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I N CLINICAL orthotopic liver transplantation (OLT), 
one of the more important factors that influence prog-
nosis in the postoperative period is the extent of liver 
injury resulting from harvesting, preservation, and reper-
fusion of the donor organ. I 
Agents that either enhance the reparative process or 
protect the liver from cellular damage are referred to as 
"hepatotrophic." Cyclo~porine A (CyA), a powerful im-
munosuppressive agent used clinically to prevent allograft 
rejection. has been shown to possess significant hepa-
totrophic action in the rat studied after partial hepa-
tectomy.2-S Recently, FK 506. an even more powerful new 
immunosuppressive agent. bas been shown to possess 
similar if not greater hepatotrophic activity. 5 
The purpose of the present study was to examine the 
efficacy of FK 506 in ameliorating the hepatic injury associ-
ated with experimental ischemia and reperfusion in rats. 
MATERIALS AND METHODS 
Male Lewis rats weighing 200-300 g were used for all of the 
experiments. A 6O-minute period of total ischemia of the right 
lateral lobe of the liver was induced by occluding the right portal 
vein and hepatic artery using microvascular clamps under meto-
fane inhalation anesthesia. This te,::hnique avoids occlusion of the 
left portal vein and the left hepatic artery during the ischemic 
period which, were they occluded, would result in splanchnic 
pooling of blood which can be lethal.6 Immediately after reperfu-
sion, the nonischemic median and left lateral lobes of the liver 
were excised using the method of Higgins and Anderson. 7 
Prior to the hepatic ischemia. the rats were assigned to one of 
three different experimental groups (10 rats each). In group I 
(controls), 0.5 mL of saline solution was administered IV via the 
inferior vena cava (lVe) 30 minutes after the initiation of the 
ischemia. In groups 2 and 3. 0.3 mg 'kg of FK 506 were injected IV 
30 minutes after and 24 hours before the initiation of the hepatic 
ischemia, respectively. 
In a second experiment. five rats in groups 1 and 3 were killed 
at 24-hour intervals. from time 0 (end of the surgical procedure) to 
72 hours after the operation. Immediately before killing. blood 
samples were obtained from each rat for the purpose of measuring 
serum levels of alanine aminotransferase (ALT) and lactate dehy-
drogenase (LDH). At the same time. a portion of the previously 
ischemic right hepatic lobe was fr«ze-clamped in liquid nitrogen 
for determination of its adenosine triphosphate (ATP) content. 
All data are reported as mean .... a1ues ~ SEM. Comparisons 
between the means for each group were performed using Stu-
dent's I test. The chi-square test 'iIoith the Yates correction was 
used to compare the proportions 0( surviving rats between groups. 
A P value of <.05 was considered 10 be statistically significant. 
RESULTS 
The control rats (100%) died within 72 hours after the 
initiation of the ischemia. The JO-day survival rates for the 
rats in groups 2 and 3 were, respectively, 30% and 80% (P 
< .01) (Fig I). 
FK S06 pretreatment significantly increased the hepatic 
A TP content at each time interval considered with respect 
to the control group (P < .OS)_ In the FK S06 pretreatment 
group, the hepatic ATP content returned to preischemic 
values (3-3.S /.wmolfg) within 24 hours and was maintained 
at that level thereafter (Fig 2). 
In both the control and the FK S06 pretreatment groups, 
an increase in the level of AL T was observed at time 0 and 
at 24 hours postoperatively but declined thereafter. When 
the peak values were compared between groups. the ALT 
level was significantly lower in the rats pretreated with FK 
5()6 than in the control rats at 48 hours postoperatively (P 
< .OS). Moreover, the ALT level in the FK 506-pretreated 
rats reached the normal range (preischemic) at 72 hours 
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FIg 1. Percent survival at 10 days of the animals studied (+ = P 
< .01). 
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Fig 2. Hepatic ATP content in the animals studied. Points 
represent mean values and bracket represent SEM (* = P < .05). 
postischemia (Fig 3). Finally, the LDH level was signifi 
cantly lower in the FK 506-pretreated rats compared with 
the levels seen in the control rats at 24 and 48 hours 
postischemia (P < .05) (Fig 4). 
DISCUSSION 
In this model, a 70% hepatectomy involving the median 
and left lateral hepatic lobes is performed immediately 
after a 6O-minute period of total ischemia of the right 
lateral lobe of the liver. Subsequent survival of the rats is 
dependent upon the ability of the residual ischemic right 
lobe of the liver to regenerate and recover from the 
ischemic injury. 
Previous experiments have shown that the hepatic con-
tent of DNA and the mitotic activity in the liver of the rat 
after a 70% hepatectomy increase significantly as a result 
of CyA exposure, and even more markedly follo .... ing 
exposure to FK 506.5 Furthermore, in the dog Eck-fistula 
model, CyA has been shown to prevent hepatocellular 
atrophy and to increase the low rate of hepatocyte hyper-
ul~----------------------------------I 
::I 200 
• e 
; 100 
0 
-2. 0 2. "2 
Fig 3. Serum AL T levels in the animals Studied. Points represent 
mean values and brackets represent SEM (* = P < .05). 
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Fig 4. Serum LDH levels in the animals studied. Points represent 
mean values and brackets rep!"esent SEM (* = P < 0.05). 
plasia characteristic of the model. The effect of an infusion 
of FK 506 at a much lower dose in this model was similar. B 
The possibility of a link between the immune system and 
hepatic regeneration has been suggested.5 •9 •10 It is con-
ceivable that ischemic hepatic injury may activate a cyto-
toxic autoimmune reaction against hepatocytes and other 
cells present in the liver, as a consequence of an induced 
structural alteration of the liver ceU membrane caused by 
ischemia, and thereby impair the ability of liver cells to 
regenerate. II It is equally possible that the hepatotrophic 
qualities of FK 506 and CyA are independent from immu-
nosuppression as has been discussed by Starzl et al. 12 A 
biochemical mechanism is supported by our demonstra-
tion of a faster and more complete restoration of hepatic 
ATP. We conclude that FK 506 pretreatment maintains the 
hepatic ATP content and reduces the extent of De(:rosis 
following hepatic ischemia. These actions may allow the 
liver to regenerate and r~over from the ischemic injury. 
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